Access to Medicines

Sign up to receive updates about our work in Health.

Access to Medicines

Access to Medicines

Despite advances in medical science, affordable safe and effective medicines remain inaccessible to billions of people worldwide. The Open Society Foundations support efforts to increase access to essential medicines for people in low-resource countries, especially for poor and marginalized populations.

Learn More

Contact Us

Questions about our work on this topic? Please use this contact box.

Programs

The following Open Society programs focus on this topic.

More on the ideas and programs behind our work: Access to Medicines. Hide info

Recent Work

Publication
Lost in Transition: Three Case Studies of Global Fund Withdrawal in South Eastern Europe

These case studies from Macedonia, Montenegro, and Serbia highlight the challenges of transition to domestic financing of HIV programs after the withdrawal of the Global Fund to Fight AIDS, Tuberculosis, and Malaria.

Event
An Evening with Drs. Chris Beyrer and Jennifer Leaning

The Open Society Public Health Program hosts an evening event with Drs. Chris Beyrer and Jennifer Leaning in honor of their years of service on the Public Health Program Advisory Board.

Voices
The World Must Learn from Hong Kong’s Example

While many policymakers work to control heroin dependence, Hong Kong stands out. A new report explains why—and offers lessons to public officials hoping to follow its example.

Report
Globally Informed, Locally Responsive

Globally Informed, Locally Responsive presents a model for how localities can review best practices from other treatment delivery contexts and then adapt these recommendations to their local contexts.

Publication
Using the UN Human Rights System to Advocate for Access to Palliative Care and Pain Relief

This toolkit is a guide to using the United Nations human rights system to advocate for increased access to palliative care and pain relief as a human right.

Voices
The War on Drugs Is Holding Science Back

The Schedule 1 drug law classification used by the United Kingdom and the United States slows scientific knowledge and human progress in the name of a discredited approach to regulating drugs.